0 items USD 0.00Search
Your search for "globaldata relapsed chronic lymphocytic leukemia cll global clinical trials review h1 2018" gave back 688391 results.
Acalabrutinib (ACP-196) is an orally active, irreversible, and highly selective second-generation BTK inhibitor. Acalabrutinib binds covalently to...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Cladribine, sold under the brand name Leustatin among others, is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global Phosphoinositide 3-Kinase Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Cladribine, sold under the brand name Leustatin among others, is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Acute Myeloid Leukemia Treatment market size was valued at US$ 578.8 million in 2023. With growing demand in downstream market, the Acute...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Idarubicin market size was valued at US$ million in 2023. With growing demand in downstream market, the Idarubicin is forecast to a...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global CD20 Target Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of...
Catalog:
GIR
November 2023
Price: USD 3,480.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
T-cell acute lymphoblastic leukemia (T-ALL) is a type of acute lymphoblastic leukemia, with features similar to lymphoma. It affects white blood...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Fludarabine Phosphate market size was valued at US$ million in 2023. With growing demand in downstream market, the Fludarabine Phosphate...
Catalog:
LPI
March 2024
Price: USD 3,660.00
